Associate Professor of Pediatrics, Oregon Health and Sci University
Pediatric Hematology & Oncology
Dr. Linda C. Stork, MD
|
|
Give Review
Linda Stork works in the field of Pediatric Hematology & Oncology. He studied medicine at Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is a top medical university. Columbia University College of Physicians & Surgeons has a rank of 8 in research and a 52 in primary care He over the years received 1 awards: "Portland Monthly Magazine". Linda C. Stork is a published doctor. He published 44 publications, including: 'Congenital subcutaneous nodule in an infant.'
Publications
- Reply to: Obesity is an important health problem in survivors of pediatric Acute lymphoblastic leukemia.
- Outcome of Children with Standard-Risk T-Lineage Acute Lymphoblastic Leukemia-Comparison among Different Treatment Strategies.
- Preventive antibiotics in pediatric patients with Acute myeloid leukemia (AML).
- Survivors of standard risk Acute lymphoblastic leukemia do not have increased risk for overweight and obesity compared to non-cancer peers: A report from the Children'...
- Family life events in the first year of Acute lymphoblastic leukemia therapy: A children's oncology group report.
- TPMT and MTHFR genotype is not associated with altered risk of thioguanine-related sinusoidal obstruction syndrome in pediatric Acute lymphoblastic leukemia: A report ...
- Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease.
- Imatinib mesylate causes growth deceleration in pediatric patients with chronic myelogenous Leukemia.
- Escalating intravenous methotrexate improves event-free survival in children with standard-risk Acute lymphoblastic leukemia: a report from the Children's Oncology Group.
- Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk Acute lymphoblastic leukemia: report of the Children's Oncolo...
- Use of rituximab for refractory cytopenias associated with autoImmune lymphoproliferative syndrome (ALPS).
- Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952.
- Primary ocular adnexal Lymphoma in pediatric patients: report of two cases and review of the literature.
- Disseminated nasopharyngeal natural killer cell lymphoblastic Lymphoma in a child.
- Molecular genetic analysis of a small bowel primitive neuroectodermal tumor.
- Pancytopenia in propionic acidemia: hematologic evaluation and studies of hematopoiesis in vitro.
- Interleukin-1 enhances murine granulopoiesis in vivo.
- Congenital subcutaneous nodule in an infant.
- Solitary Renal myofibromatosis: an unusual cause of infantile hypertension.
- Acute megakaryoblastic leukemia in Down syndrome: orbital infiltration.
- The discriminating value of serum lactate dehydrogenase levels in children with Malignant neoplasms presenting as joint pain.
- Interleukin-1 accelerates murine granulocyte recovery following treatment with cyclophosphamide.
- Cytogenetic abnormalities in a case of botryoid rhabdomyosarcoma.
- Changes in plasma methionine and total homocysteine levels in patients receiving methotrexate infusions.
- Meta-analysis of randomised trials comparing thiopurines in childhood Acute lymphoblastic leukaemia.
- Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with Acute lymphoblastic leukemia.
- Plasma pharmacokinetics and cerebrospinal fluid penetration of thioguanine in children with Acute lymphoblastic leukemia: a collaborative Pediatric Oncology Branch, NC...
- Cessation of antibiotics regardless of ANC is safe in children with febrile Neutropenia. A preliminary prospective trial.
- N-ras gene mutations in childhood Acute non-lymphoblastic leukemia.
- Heterogeneity of Acute "undifferentiated" leukemia of childhood: ultrastructural, immunophenotypic, and karyotypic analyses.
- TEL-AML1 fusion identifies a subset of children with standard risk Acute lymphoblastic leukemia who have an excellent prognosis when treated with therapy that includes...
- A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard...
- A case of childhood peripheral T-cell Lymphoma with massive cardiac infiltration.
- Altered patterns of T cell cytokine proDuction induced by relapsed pre-B ALL cells.
- Portal hypertension develops in a subset of children with standard risk Acute lymphoblastic leukemia treated with oral 6-thioguanine during maintenance therapy.
- Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatmen...
- A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood Acute lymphoblastic leukemia.
- Flow cytometric chemosensitivity assay as a predictive tool of early clinical response in Acute lymphoblastic leukemia.
- A unique case of adolescent CD56-negative extranodal NK/T-cell Lymphoma, nasal type.
- Outcome after relapse among children with standard-risk Acute lymphoblastic leukemia: Children''s Oncology Group study CCG-1952.
- Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid Tumors: the Children''s Oncology Group.
- Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk Acute lymphoblastic leukemia: a collaborativ...
- Intrathecal triple therapy decreases central Nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of th...
Schools
Columbia University College Of Physicians and Surgeons
Babies Hospital Columbia PampS
University Co Med Center
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- AdRenal Gland Cancer
- Anemia
- Bile Duct Cancer
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Choice Health PPO
- First Health (Coventry Health Care) PPO
- Health Plan of Oregon PPO
- Medicare Advantage PFFS
- Kaiser Permanente
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- ODS Health Plan
- Preferred PSN
- Personal Option EPO
- Preferred PPO
- Preferred Provider Network PPN
- Tricare
- Choice Plus POS
- Options PPO
- United Healthcare
Awards
- Portland Monthly Magazine
Education
-
University of Colorado -
New York Presbyterian Hospital - Columbia Campus -
Columbia University College of Physicians & Surgeons
Helpful Reviews
Similar Doctors
|
|
Dr. Jason M. Glover, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janice F. Olson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Billy H. Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David L. Tilford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kellie J. Nazemi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eneida R. Nemecek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shirin Doratotaj, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Louise E. Sivak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Recht, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Elsa B. Mitchell, DPT |